Location · JapanUpdated September 28, 2026

Clinical trial software for studies in Japan

Japan is one of the largest pharmaceutical markets and has specific expectations for trials that support Japanese approval. Capture keeps Japanese sites in the same global study with the controls PMDA inspectors look for.

  • Global study, Japanese sites
  • Part 11-aligned controls
  • Audit trail inspectors can read

Free sandbox · No credit card · 21 CFR Part 11 aligned

Study settings · Region
JP

Study region

Japan

Regulators
PMDA and MHLW
GCP standard
J-GCP
Other trials
Clinical Trials Act (specified trials)
Data protection
APPI
Hosting options
EU (Frankfurt) or US (N. Virginia)
AES-256 at rest TLS in transit Chosen at study setup

Key points for studies in Japan

  • Trials supporting drug approval (chiken) are notified to and overseen by the Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labour and Welfare (MHLW), and follow J-GCP.
  • Other clinical research with medicines may fall under the Clinical Trials Act, with registration in the Japan Registry of Clinical Trials (jRCT).
  • Personal data is governed by the Act on the Protection of Personal Information (APPI), which regulates transfers to third parties abroad.
  • Participant materials, and often site-facing documents, need Japanese versions.
  • Including Japanese sites in global trials early can support Japanese submissions without a separate local study, depending on the development plan.

Research landscape

Bringing Japan into a global programme

For many years, Japanese approvals often relied on separate local trials. Joining multi-regional clinical trials from the start has become common, supported by ICH guidance on multi-regional trials and regulatory consultation with PMDA. That makes it more important that Japanese sites run in the same data system, with the same definitions and controls, as sites elsewhere.

PMDA conducts GCP inspections that look closely at records, including electronic data. A field-level audit trail with readable descriptions, filters by participant and date, and export on demand helps sites and sponsors answer inspection questions quickly. See the FDA inspection checklist for the kinds of evidence regulators ask for.

APPI and cross-border transfers

The APPI requires a basis for providing personal data to third parties in foreign countries, such as consent informed about the destination, or equivalent protection measures. Keep identifying information at the site, show sponsor-side users coded IDs, and document the hosting region in the consent and study agreements.

Weight changed 68.0 to 68.5 kg

Site coordinator · Reason: Transcription error

9f2c…a71e

Query Q-0014 answered on Weight

Site coordinator · Reason: Source checked

4b8d…c203

Vital signs form locked

Data manager · Reason: Visit cleaned

e61a…58f0
Verify chain Intact

Consistency

Same definitions at every site

Approved forms are locked and identical at every site, edit checks behave the same way everywhere, and randomisation is configured once for the whole study. When the protocol is amended, all sites move to the new version together.

  • Locked, identical forms across regions.
  • One randomisation design, stratified by site or region.
  • Amendments without version drift.
Clinical trial randomization software
Randomization · stratified blocks · 1:1
Site 01

Baseline severity: moderate

Block 7 of 12

Site 01

Baseline severity: severe

Block 4 of 12

Site 02

Baseline severity: moderate

Block 6 of 12

Subject 01-0048 randomized

Blinded

Randomization no.

R-0166

Treatment arm

●●●●●●

Emergency unblinding

Built in for blinded designs, when participant safety requires it.

Stratify a sample study by region

Set up randomisation with a region factor in the free sandbox.

Build your study free

Before you start

Japan study set-up checklist

Regulatory pathway confirmed

J-GCP trial notification, or Clinical Trials Act for other research.

PMDA consultation considered

Especially for multi-regional development plans.

APPI transfer basis

Documented and reflected in consent.

Japanese materials

Approved consent, participant texts and official instrument translations.

Registry entries

jRCT or other registries as required.

Site activated

Ethics approval, contract, initiation visit and delegation log.

Terms

Japanese trial terms you will meet

TermMeaningWhy it matters for data
ChikenA clinical trial conducted to support drug or device approval.Runs under J-GCP with PMDA oversight and inspection.
J-GCPJapan's GCP ordinance, based on ICH GCP.Sets the record-keeping and monitoring expectations.
SMOSite management organisation that supports hospitals with trial staff.SMO coordinators often do data entry, so roles and delegation must be clear.
CRCClinical research coordinator at the site, often provided by an SMO.The main system user at most Japanese sites.
jRCTJapan Registry of Clinical Trials.Registration for studies under the Clinical Trials Act.
GCP inspectionPMDA review of trial conduct and records.Audit trail and source records must be retrievable.

Working with Japanese sites

Precision, documentation and the coordinator's role

Japanese sites are known for careful documentation and low error rates, and they expect the same precision from the system: clear field definitions, CRF completion guidelines translated into Japanese, and queries that explain exactly what is needed. Because many coordinators come from site management organisations, delegation and access need to be set up precisely, and changes in coordinator must be reflected in the delegation log and system roles at the same time.

For participant-reported outcomes, use official Japanese translations of validated instruments and keep the recall period and wording identical to the source. Browser-based questionnaires on participants' own phones work well in Japan, where smartphone use is high across age groups. See ePRO software.

FAQ

Questions teams ask before they switch

Something not covered here? Ask us directly.

Who regulates clinical trials in Japan?

The PMDA and MHLW oversee trials supporting drug approval, which follow J-GCP. Other clinical research may fall under the Clinical Trials Act.

What is the APPI?

Japan's Act on the Protection of Personal Information, which regulates personal data, including transfers to third parties abroad.

Can Japanese sites join a global study in Capture?

Yes. Every site runs in the same study with the same forms, checks and audit trail.

Where is data hosted for studies in Japan?

Capture hosts study data in the EU (Frankfurt) or the US (N. Virginia), chosen at study setup, with AES-256 encryption at rest and TLS in transit. Assess the cross-border transfer rules that apply to your study before choosing.

Can I try it before committing?

Yes. The free sandbox has every feature with no credit card and no time limit.

Japanese sites in your global study

Same forms, checks and audit trail everywhere. Free sandbox.

Build your study free